TABLE 2.
Clinical manifestations of COVID‐19
| Clinical manifestations | SARS‐CoV‐2 | P‐value | |
|---|---|---|---|
| Positive | Negative | ||
| Flu symptoms | 9 (8.2%) | 11 (10.0%) | .639 |
| Dizziness | 5 (4.5%) | 6 (5.5%) | .757 |
| Sore throat | 20 (18.2%) | 39 (35.5%) | .004 |
| Nausea | 13 (11.8%) | 9 (8.2%) | .369 |
| Loss of appetite | 7 (6.4%) | 0 (0.0%) | .007 |
| Fatigue | 15 (13.6%) | 9 (8.2%) | .194 |
| Otalgia | 3 (2.7%) | 6 (5.5%) | .307 |
| Coryza | 23 (20.9%) | 27 (24.5%) | .520 |
| Headache | 35 (31.8%) | 43 (40.9%) | .161 |
| Dyspnoea | 39 (35.8%) | 30 (27.3%) | .191 |
| Wheezing | 1 (0.9%) | 1 (0.9%) | 1.00 |
| Dry cough | 51 (46.4%) | 49 (44.5%) | .787 |
| Productive cough | 5 (4.5%) | 7 (6.4%) | .553 |
| Myalgia | 29 (26.4%) | 28 (25.5%) | .878 |
| Ageusia | 5 (4.5%) | 1 (0.9%) | .098 |
| Anosmia | 4 (3.6%) | 3 (2.7%) | .702 |
| Chills | 8 (7.3%) | 10 (9.1%) | .623 |
| Fever | 45 (41.3%) | 32 (27.5%) | .066 |
| Diarrhoea | 13 (11.8%) | 10 (9.1%) | .509 |
| Constipation | 1 (0.9%) | 0 (0.0%) | .316 |
| Abdominal pain | 3 (2.7%) | 2 (1.8%) | .651 |
| Chest pain | 11 (10.0%) | 10 (9.1%) | .819 |
| Tremors | 0 (0.0%) | 1 (0.0%) | .316 |
| Mental confusion | 1 (0.9%) | 0 (0.0%) | .316 |
| Total | 110 (100%) | 110 (100%) |
n = 220.